TSHA logo

TSHA
Taysha Gene Therapies Inc

2,037
Mkt Cap
$1.97B
Volume
881,054.00
52W High
$7.30
52W Low
$2.25
PE Ratio
-17.29
TSHA Fundamentals
Price
$6.55
Prev Close
$6.85
Open
$6.79
50D MA
$5.29
Beta
1.68
Avg. Volume
2.83M
EPS (Annual)
-$0.3409
P/B
9.28
Rev/Employee
$98,717.17
$1,508.72
Loading...
Loading...
News
all
press releases
Taysha Gene Therapies (NASDAQ:TSHA) Issues Earnings Results
Taysha Gene Therapies (NASDAQ:TSHA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.02...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High - Here's What Happened
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - What's Next...
MarketBeat·8d ago
News Placeholder
Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday
Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-taysha-gene-therapies-inc-stock...
MarketBeat·11d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened...
MarketBeat·21d ago
News Placeholder
Taysha Gene Therapies Sees Unusually High Options Volume (NASDAQ:TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) was the target of some unusual options trading on Thursday. Stock investors acquired 6,277 call options on the company. This is an increase...
MarketBeat·27d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 12-Month High - Still a Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 52-Week High - What's Next...
MarketBeat·27d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 9% - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 9% - Still a Buy...
MarketBeat·28d ago
News Placeholder
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Brokerages
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has received an average rating of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities...
MarketBeat·28d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells $892,000.00 in Stock
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an...
MarketBeat·29d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Insider Sukumar Nagendran Sells 200,000 Shares
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the company's stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $4.46, for a total transaction of $892,000.00. Following the sale, the insider...
MarketBeat·30d ago
<
1
2
...
>

Latest TSHA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.